No abstract available
Keywords:
First-line; Immunotherapy; Immunothérapie; Mésothéliome pleural malin; Nivolumab plus ipilimumab; Pleural mesothelioma; Première ligne.
MeSH terms
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Humans
-
Ipilimumab / therapeutic use*
-
Mesothelioma, Malignant / drug therapy*
-
Nivolumab / therapeutic use*
-
Pleural Neoplasms / drug therapy*
Substances
-
Antineoplastic Agents, Immunological
-
Ipilimumab
-
Nivolumab